Meridian Bioscience (VIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Sales | 84,797 | 57,296 | 47,421 | 50,846 | 48,440 |
| Cost of Goods | 28,814 | 22,750 | 19,770 | 21,287 | 20,181 |
| Gross Profit | 55,983 | 34,546 | 27,651 | 29,559 | 28,259 |
| Operating Expenses | 22,132 | 23,505 | 23,027 | 23,997 | 21,976 |
| Operating Income | 34,665 | 11,791 | 5,394 | 5,849 | 6,464 |
| Interest Expense | 703 | 532 | 767 | 787 | 448 |
| Other Income | 911 | 1,388 | -601 | 294 | 462 |
| Pre-tax Income | 34,873 | 12,647 | 4,026 | 5,356 | 6,478 |
| Income Tax | 7,366 | 3,288 | 1,199 | 1,253 | 1,399 |
| Net Income Continuous | 27,507 | 9,359 | 2,827 | 4,103 | 5,079 |
| Net Income | $27,507 | $9,359 | $2,827 | $4,103 | $5,079 |
| EPS Basic Total Ops | 0.64 | 0.22 | 0.07 | 0.09 | 0.12 |
| EPS Basic Continuous Ops | 0.64 | 0.22 | 0.07 | 0.10 | 0.12 |
| EPS Diluted Total Ops | 0.64 | 0.22 | 0.07 | 0.09 | 0.12 |
| EPS Diluted Continuous Ops | 0.64 | 0.22 | 0.07 | 0.10 | 0.12 |
| EBITDA(a) | $38,143 | $14,739 | $8,334 | $9,051 | $9,006 |